%PDF-1.5
%
10 0 obj
<>/Metadata 7 0 R/Pages 1 0 R/StructTreeRoot 3 0 R/Type/Catalog>>
endobj
7 0 obj
<>stream
uuid:f7b65305-1dd1-11b2-0a00-1e0000000000
uuid:F4C66644-43F2-CD79-A4EA-16E06C643615
2021-07-19T22:15:08+05:30
2024-03-19T05:50:09-07:00
PTC Arbortext Advanced Print Publisher 11.1.4012/W
2024-03-19T05:50:09-07:00
PDFlib+PDI 9.0.3p4 (C++/Win32)
application/pdf
KV-ASPET-JPET210056 1..1
PStill version 1.84.42
endstream
endobj
1 0 obj
<>
endobj
3 0 obj
<>
endobj
5 0 obj
<>]/Lang(en)/P 3 0 R/Pg 11 0 R/S/Document/Type/StructElem>>
endobj
4 0 obj
<>
endobj
6 0 obj
[5 0 R]
endobj
11 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 1/Tabs/S/TrimBox[0 0 585.071 782.929]/Type/Page>>
endobj
57 0 obj
[58 0 R 66 0 R]
endobj
63 0 obj
<>stream
/Artifact BMC
549.482 646.319 m
35.6031 646.319 l
35.6031 647.319 l
549.482 647.319 l
f*
EMC
/Document <>BDC
BT
/T1_0 1 Tf
0.00999 Tc 11.9999 0 0 11.9999 140.031 738.255 Tm
[(The )8.9 (Journal )6.3 (of )]TJ
ET
BT
/T1_1 1 Tf
0 Tc 32 0 0 32 138.557 705.317 Tm
(PHARMACOLOGY )Tj
ET
BT
/T1_0 1 Tf
11.9551 0 0 11.9551 240.718 680.258 Tm
[(And )-0.9 (Experimental )-8.9 (Therapeutics )]TJ
ET
BT
/T1_2 1 Tf
10 0 0 10 93.77 655.257 Tm
[(A )-49.1 (Publication )-57.7 (of )-57.9 (the )-54.5 (American )-52 (Society )-58 (for )-53.7 (Pharmacology )-58.5 (and )-56.9 (Experimental )-55.8 (Therapeutics )]TJ
ET
BT
/T1_2 1 Tf
11.9999 0 0 11.9999 35.6031 629.348 Tm
[(July )-55 (2021 \
)]TJ
36.1278 0 Td
[(V)51.8 (ol. )-51.2 (378, )-54.4 (No. )-52 (1 )]TJ
ET
BT
/T1_0 1 Tf
11.9551 0 0 11.9551 262.885 608.372 Tm
(Contents )Tj
ET
BT
/C2_0 1 Tf
10 0 0 10 35.6031 576.34 Tm
<0025002300340026002B003100380023003500250037002E0023003400020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002>Tj
ET
BT
/T1_3 1 Tf
9 0 0 9 540.51 559.332 Tm
(10 )Tj
-54.148 0 Td
[(Rosuvastatin )-32.1 (Inhibits )-33.9 (the )-33.8 (Apoptosis )-27.6 (of )-31.9 (Platelet-Derived )-40.2 (Growth )-26 (Factor\261Stimulated )-36.6 (Vascular )-34.5 (Smooth )-31.3 (Muscle )-36.5 (Cells )-33.3 (by )]TJ
0 -1.222 TD
[(Inhibiting )-32.4 (p38 )-26.4 (via )-33.8 (Autophagy )]TJ
/T1_4 1 Tf
1.0709 -1.222 Td
[(Jun-Hwan )-83.6 (Jo, )-83.7 (Hyun-Soo )-85.9 (Park, )-86.3 (Do-Hyung )-88.3 (Lee, )-82.3 (Joo-Hui )-86.8 (Han, )-87.5 (Kyung-Sun )-85.1 (Heo, )-83.8 (and )-83.1 (Chang-Seon )-82.7 (Myung )]TJ
ET
BT
/C2_0 1 Tf
10 0 0 10 35.6031 519.477 Tm
[<00260034003700290002>-54.8 <0026002B003500250031003800270034003B0002>-56.8 <0023003000260002>-56.2 <00360034002300300035002E00230036002B003100300023002E0002>-55.7 <002F00270026002B0025002B00300027000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002>]TJ
ET
BT
/T1_3 1 Tf
9 0 0 9 544.989 502.469 Tm
(1 )Tj
-54.6456 0 Td
[(The )-28.4 (Caveolin-1 )-38.3 (Scaffolding )-33.4 (Domain )-31.7 (Peptide )-30.2 (Reverses )-32.9 (Aging-Associated )-35.7 (Deleterious )-37 (Changes )-34.2 (in )-27.3 (Multiple )-35.7 (Organs )]TJ
/T1_4 1 Tf
1.0708 -1.2472 Td
[(Dhandapani )-86.5 (Kuppuswamy, )-83.3 (Panneerselvam )-92.4 (Chinnakkannu, )-84.2 (Charles )-88.4 (Reese, )-82.8 (and )-83.1 (Stanley )-88.5 (Hof)-56.9 (fman )]TJ
ET
BT
/C2_0 1 Tf
10 0 0 10 35.6031 473.442 Tm
[<002F00270036002300240031002E002B0035002F000E0002>-52.3 <003600340023003000350032003100340036000E0002>-59.1 <0023003000260002>-56.2 <0032002A00230034002F00230025003100290027003000270036002B0025003500020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002>]TJ
ET
BT
/T1_3 1 Tf
9 0 0 9 540.51 456.435 Tm
(42 )Tj
/T1_5 1 Tf
-54.148 0 Td
(\r)Tj
/T1_3 1 Tf
0.548 0 Td
[(-Hydroxybutyric )-35.1 (Acid\261Ethanol )-32.9 (Drug-Drug )-33.2 (Interaction: )-38.6 (Reversal )-29.9 (of )-31.9 (Toxicity )-31.1 (with )-29.8 (Monocarboxylate )-39.5 (Transporter )-34.5 (1 )]TJ
-0.548 -1.222 Td
(Inhibitors )Tj
/T1_4 1 Tf
1.0709 -1.222 Td
[(Vivian )-87.6 (Rodriguez-Cruz )-84 (and )-83 (Marilyn )-88.4 (E. )-82.9 (Morris )]TJ
ET
BT
/C2_0 1 Tf
10 0 0 10 35.6031 416.579 Tm
<003000270037003400310032002A00230034002F002300250031002E00310029003B00020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002000200020002>Tj
ET
BT
/T1_3 1 Tf
9 0 0 9 540.51 399.572 Tm
(20 )Tj
-54.148 0 Td
[(TPN672: )-34.6 (A )-27.3 (Novel )-31.6 (Serotonin-Dopamine )-35.6 (Receptor )-34.5 (Modulator )-33.2 (for )-26.5 (the )-33.9 (Treatment )-34.7 (of )-32 (Schizophrenia )]TJ
/T1_4 1 Tf
1.0709 -1.2472 Td
[(Yu )-83.8 (Wang, )-83.5 (Yang )-85.4 (He, )-79.9 (Feipu )-85.2 (Yang, )-87.4 (Melkamu )-87 (Alemu )-81.3 (Abame, )-91.1 (Chunhui )-82.5 (Wu, )-82 (Yanmin )-81.6 (Peng, )-91 (Linyin )-80.3 (Feng, )-84.7 (Jingshan )-86.6 (Shen, )]TJ
T*
[(Zhen )-81.7 (Wang, )-83.5 (and )-83.1 (Ling )-83.9 (He )]TJ
ET
BT
/C2_0 1 Tf
10 0 0 10 35.6031 359.546 Tm
<00360031003A002B00250031002E00310029003B0002>Tj
ET
35.6031 350.816 m
35.9433 350.816 l
35.9433 344.183 l
35.6031 344.183 l
f*
41.2157 350.816 m
41.6126 350.816 l
41.6126 344.183 l
41.2157 344.183 l
f*
35.6031 350.816 m
41.6126 350.816 l
41.6126 350.476 l
35.6031 350.476 l
f*
35.6031 344.523 m
41.6126 344.523 l
41.6126 344.183 l
35.6031 344.183 l
f*
BT
/T1_6 1 Tf
9 0 0 9 36.8503 345.543 Tm
(s)Tj
/T1_3 1 Tf
55.9622 -0.0881 Td
(31 )Tj
-54.1481 0 Td
[(A )-33.6 (p97/Valosin-Containing )-33.4 (Protein )-30.8 (Inhibitor )-33.1 (Drug )-29.7 (CB-5083 )-34.6 (Has )-26.8 (a )-33.7 (Potent )-29.9 (but )-31.2 (Reversible )-36.3 (Off-Target )-34.6 (Effect )-35.1 (on )]TJ
0 -1.2221 TD
(Phosphodiesterase-6 )Tj
/T1_4 1 Tf
1.0709 -1.222 Td
[(Henri )-64.7 (Leinonen, )-69 (Cheng )-66.2 (Cheng, )-68.1 (Marja )-66.7 (Pitk)]TJ
/T1_6 1 Tf
17.5559 0 Td
()Tj
/T1_4 1 Tf
-0.063 0 Td
[(anen, )-66.4 (Christopher )-66.4 (L. )-69.3 (Sander, )-63.3 (Jianye )-69.7 (Zhang, )-66.1 (Sama )-64.3 (Saeid, )-68.9 (Teemu )-65.5 (Turunen, )]TJ
-17.4929 -1.2221 Td
[(Alyaa )-85.2 (Shmara, )-82 (Lan )-87.8 (Weiss, )-85.5 (Lac )-84.1 (Ta, )-79.5 (Timothy )-86.7 (Ton, )-83.4 (Ari )-82.6 (Koskelainen, )-89.3 (Jesse )-89.4 (D. )-79.7 (Vargas, )-86.8 (Virginia )-86.8 (Kimonis, )-87.1 (and )]TJ
0 -1.222 TD
[(Krzysztof )-85.4 (Palczewski )]TJ
ET
/Artifact BMC
35.6031 65.6685 m
549.652 65.6685 l
548.652 64.6685 l
36.6032 64.6685 l
f*
549.652 65.6685 m
549.652 20.9424 l
548.652 21.9424 l
548.652 64.6685 l
f*
549.652 20.9424 m
35.6031 20.9424 l
36.6032 21.9424 l
548.652 21.9424 l
f*
35.6031 20.9424 m
35.6031 65.6685 l
36.6032 64.6685 l
36.6032 21.9424 l
f*
EMC
35.6031 89.7449 m
35.9433 89.7449 l
35.9433 83.1118 l
35.6031 83.1118 l
f*
41.2157 89.7449 m
41.6126 89.7449 l
41.6126 83.1118 l
41.2157 83.1118 l
f*
35.6031 89.7449 m
41.6126 89.7449 l
41.6126 89.4047 l
35.6031 89.4047 l
f*
35.6031 83.452 m
41.6126 83.452 l
41.6126 83.1118 l
35.6031 83.1118 l
f*
BT
/T1_6 1 Tf
9 0 0 9 36.8503 84.4724 Tm
(s)Tj
ET
BT
/C2_1 1 Tf
7.9999 0 0 7.9999 47.2818 83.6787 Tm
[<0035005700520052004E0047004F0047005000560043004E0002>2.6 <004F0043005600470054004B0043004E0002>-2.9 <004B00550002>-7 <004300580043004B004E00430044004E00470002>-1.9 <004300560002>-2.9 <004C005200470056001000430055005200470056004C00510057005400500043004E0055001000510054004900100002>]TJ
/C2_2 1 Tf
0.2267 -4.5992 Td
[<002300440051005700560002>45.8 <0056004A00470002>40.9 <00450051005800470054>]TJ
/C2_1 1 Tf
[<001C0002>44 <002F0025003600130002>48.9 <004B0050004A004B0044004B0056005100540002>39.5 <0023003C00260015001B001800170002>49.1 <005400470058004700540055004700550002>40 <0056004A00470002>48.9 <00470050004A004300500045004700460002>43.2 <00560051005A004B0045004B0056005B0002>40.2 <005100440055004700540058004700460002>43.3 <0059004B0056004A0002>46.6 <00470056004A004300500051004E0002>46.6 <00450051000F00430046004F004B0050004B00550056005400430056004B005100500002>41.7 <0059004B0056004A0002>46.6 <0029002A002400100002>40.2 <0035004700470002>51.3 <0056004A00470002>]TJ
0 -1.2543 TD
[<004300540056004B0045004E00470002>-54.3 <0044005B0002>-60.5 <0034005100460054004B004900570047005C000F002500540057005C0002>-51 <0043005000460002>-57.4 <002F005100540054004B00550002>-56.1 <000A0046005A001000460051004B0010005100540049001100130012001000130013001400160011004C00520047005600100013001400130010001200120012001700180018000B001000020002>]TJ
ET
EMC
BT
/T1_7 1 Tf
0 -9 9 0 568 389.00652 Tm
( at ASPET Journals on March 19, 2024)Tj
-8.61 0 Td
(jpet.aspetjournals.org)Tj
-7.55399 0 Td
(Downloaded from )Tj
ET
q
0 648 -22.5 0 22.5 66.5 cm
1.2543 TL /Im0 Do
Q
endstream
endobj
65 0 obj
<>/Filter/FlateDecode/Height 90/Length 28755/Name/X/Subtype/Image/Type/XObject/Width 2592>>stream
HOPq.]͌,fKYq1.1FhRL&LMHK#1G YF:MJ6QҰ&m
m֩˸ѩ3.>Y쳻?~ós Ee@u
y{@u
*UG # lTG m# l 6GTG 'uUG w {# l* 6Qã# lOP `ۡ: 1 6ᾝ# lZu
Zu
}Fu nx~!1:yOuʧ62۷.3:iK_Z^, ~Ku ,xHC
MrËUu"Wވb.Tu`q
h>>: Ee~u_::QnI}kFoDB^Xҳw\ntdXE*\ru8K}/8dk=.$܈not||RۺBD`qXV8m} Soޭ: "tOsb@)6IJ; y8ɶҚB7tdJɭ勷Y|,$W\j=wfj(ykjw_QGhǑ
`CaJKz3y/ݝYyg.3Wpع^y̪i?^ZSykɺ
A/Kswm2ܸ S;FK#iTv5eɛ56嬲v7㤻Am紻FG{RB2JdŖϨSr==r